- Home
- SID vs CNTA Comparison
SID vs CNTA Comparison
Compare SID & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SID
- CNTA
- Stock Information
- Founded
- SID 1941
- CNTA 2020
- Country
- SID Brazil
- CNTA United Kingdom
- Employees
- SID N/A
- CNTA N/A
- Industry
- SID Steel/Iron Ore
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- SID Industrials
- CNTA Health Care
- Exchange
- SID Nasdaq
- CNTA Nasdaq
- Market Cap
- SID 2.0B
- CNTA 2.2B
- IPO Year
- SID 1997
- CNTA 2021
- Fundamental
- Price
- SID $1.55
- CNTA $16.23
- Analyst Decision
- SID Sell
- CNTA Strong Buy
- Analyst Count
- SID 2
- CNTA 8
- Target Price
- SID $2.95
- CNTA $23.17
- AVG Volume (30 Days)
- SID 1.8M
- CNTA 1.1M
- Earning Date
- SID 03-12-2025
- CNTA 03-27-2025
- Dividend Yield
- SID 14.38%
- CNTA N/A
- EPS Growth
- SID N/A
- CNTA N/A
- EPS
- SID N/A
- CNTA N/A
- Revenue
- SID $8,019,254,042.00
- CNTA $6,853,000.00
- Revenue This Year
- SID N/A
- CNTA N/A
- Revenue Next Year
- SID $6.59
- CNTA N/A
- P/E Ratio
- SID N/A
- CNTA N/A
- Revenue Growth
- SID N/A
- CNTA N/A
- 52 Week Low
- SID $1.27
- CNTA $7.75
- 52 Week High
- SID $3.29
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- SID 53.86
- CNTA 48.67
- Support Level
- SID $1.27
- CNTA $14.62
- Resistance Level
- SID $1.57
- CNTA $16.21
- Average True Range (ATR)
- SID 0.07
- CNTA 1.21
- MACD
- SID -0.00
- CNTA 0.03
- Stochastic Oscillator
- SID 78.57
- CNTA 56.49
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.